Pitoia F - Search Results

1

Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint.

Trimboli P, Bojunga J, Deandrea M, Frasca F, Imperiale A, Leoncini A, Paone G, Pitoia F, Rotondi M, Sadeghi R, Scappaticcio L, Treglia G, Piccardo A. Trimboli P, et al. Among authors: pitoia f. Endocrine. 2024 Sep;85(3):1035-1040. doi: 10.1007/s12020-024-03825-0. Epub 2024 Apr 16. Endocrine. 2024. PMID: 38625504 Free PMC article. Review.

2

Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma.

Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Rezzónico JN, et al. Among authors: pitoia f. Metab Syndr Relat Disord. 2009 Aug;7(4):375-80. doi: 10.1089/met.2008.0062. Metab Syndr Relat Disord. 2009. PMID: 19320560

3

Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?

Niepomniszcze H, Pitoia F, Goodall C, Manavela M, Bruno OD. Niepomniszcze H, et al. Among authors: pitoia f. Thyroid. 2001 Oct;11(10):991. doi: 10.1089/105072501753211091. Thyroid. 2001. PMID: 11716050 No abstract available.

4

Protocol for thyroid remnant ablation after recombinant TSH in thyroid carcinoma.

Pitoia F, El Tamer E, Salvai ME, Niepomniszcze H. Pitoia F, et al. Medicina (B Aires). 2009;69(1 Pt 2):148-52. Medicina (B Aires). 2009. PMID: 19414296

5

Recombinant human TSH: the Argentinean experience.

Pitoia F, Niepomniszcze H. Pitoia F, et al. Thyroid. 2009 Jul;19(7):799. doi: 10.1089/thy.2008.0259. Thyroid. 2009. PMID: 19508122 No abstract available.

6

Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions.

Pacini F, Ito Y, Luster M, Pitoia F, Robinson B, Wirth L. Pacini F, et al. Among authors: pitoia f. Expert Rev Endocrinol Metab. 2012 Sep;7(5):541-554. doi: 10.1586/eem.12.36. Expert Rev Endocrinol Metab. 2012. PMID: 30780891

7

Primary thyroid disorders in endogenous Cushing's syndrome.

Niepomniszcze H, Pitoia F, Katz SB, Chervin R, Bruno OD. Niepomniszcze H, et al. Among authors: pitoia f. Eur J Endocrinol. 2002 Sep;147(3):305-11. doi: 10.1530/eje.0.1470305. Eur J Endocrinol. 2002. PMID: 12213667

8

Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.

Pitoia F, Abelleira E, Jerkovich F, Urciuoli C, Cross G. Pitoia F, et al. Arch Endocrinol Metab. 2015 Aug;59(4):347-50. doi: 10.1590/2359-3997000000059. Arch Endocrinol Metab. 2015. PMID: 26331323

9

Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.

Pitoia F, Abelleira E, Román-González A, Danilovic DLS, Scheffel RS, Maia AL, Hoff AO, Califano I. Pitoia F, et al. Thyroid. 2024 Jul;34(7):949-952. doi: 10.1089/thy.2024.0090. Epub 2024 Jun 3. Thyroid. 2024. PMID: 38757613

10

[Response to lenvatinib in a pediatric patient with respiratory failure associated with papillary thyroid carcinoma].

Dujovne N, Lucero MB, Gazek N, Pitoia F, Felipe L, Ayarzabal V, López Marti J, Ciaccio M, Herzovich V. Dujovne N, et al. Among authors: pitoia f. Arch Argent Pediatr. 2021 Feb;119(1):e70-e74. doi: 10.5546/aap.2021.e70. Arch Argent Pediatr. 2021. PMID: 33458996 Free article. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters